abstract |
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula, Formula (I), wherein A, B, X, Y, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of threating arthritis, inflammation, cancer and other disorders. |